Research - Palo Alto, California, United States
CombImmune is a medical oncology and diagnostic company which intends to design and market novel immunotherapeutic and diagnostic tools related to the oncology and hematology marketplace. CombImmune represents a new paradigm in immunotherapy drug-development as well as diagnostic tumor-type prognostication. CombImmune's mission is to utilize prognostic and predictive biomarkers which inform us about the immune dysfunction to the tumor infilitration in combination with therapeutics which restore immune function and destruction of the tumor.
Nginx
Google AdSense
Mobile Friendly